This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ridker, P. M. et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab : a secondary analysis from the CANTOS randomised controlled trial. Lancet http://dx.doi.org/10.1016/S0140-6736(17)32814-3 (2017)
Rights and permissions
About this article
Cite this article
Huynh, K. Association between hsCRP reduction and cardiac outcomes. Nat Rev Cardiol 15, 2–3 (2018). https://doi.org/10.1038/nrcardio.2017.203
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2017.203